Author:
Vanninen E.,Kuikka J. T.,Tenhunen-Eskelinen M.,Mussalo H.,Vanninen R.
Reference12 articles.
1. Verhoeff NPLG, Buell U, Costa DC, Kirsch G, Lottes G, Moretti JL, Podreka I, Schober O, van Royen EA. Basics and recommendations for brain SPECT. Nuclear Medizin 1992; 31: 114–131.
2. Sullivan HG, Kingsbury TB, Morgan ME, Jeffcoat RD, Allison JD, Goode JJ, McDonnell DE. The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg 1987; 67: 525–534.
3. Bonte FJ, Devous MD, Reisch JS. The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single photon emission computed tomography. Invest Radiol 1988; 23: 564–568.
4. Knop J, Thie A, Fuchs C, Siepman G, Zeumer H. 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease. Stroke 1992; 23: 1733–1742.
5. Steele PP, van Dyke D, Trow RS, Anger HO, Davies H. Simple and safe method for serial measurement of left ventricular ejection fraction, cardiac output, and pulmonary blood volume. Br Heart J 1974; 36: 122–131.